New osteosarcoma treatment receives rare pediatric disease designation from the FDA
Innova Therapeutics Inc., a biotechnology company dedicated to developing innovative cancer therapies for patients who have inadequate treatment options, recently announced that the U.S. Food and Drug Administration (FDA) ...
Oct 2, 2020
0
4